Schedule 13D ownership disclosure

Rocket Pharmaceuticals Inc

Security class unavailable · CUSIP: 77313F106

Event date: 2018-01-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-18-000308
Form type
SC 13D/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Jan 19, 2018
Reporting period
Jan 19, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D/A | SEC Filings Hub